A Venture Capital firm based in the USA looks to make Series A equity investments ranging from $250,000 to $1.5 million in the initial round with up to $3 million reserved for follow on financing. Only on a case-by-case basis will the firm look to make seed investments. The firm focuses on companies in the United States and may also consider exceptional opportunities in Canada.
The firm is interested in investing in companies in the Medical Device, Diagnostics and to a much lesser extent Therapeutics spaces. The firm has a much stronger focus on devices with approximately 75% of the firm’s investments to date falling into those sectors. For Medical Devices the firm generally looks for companies that have either an early prototype or proof-of-concept data to support them. The firm is also currently interested in companies working with diagnostic devices and is not looking for companies in Orthopedics and Pain. For therapeutics companies the firm generally makes investment in pre-clinical assets and will evaluate opportunities on a case-by-case basis with priority given to less capital intensive opportunities.
The firm seeks privately held companies and maintains very positive and productive working relationships with its portfolio companies, providing as much assistance as needed. The firm is much more open to taking significant scientific and technical risk as opposed to sales and marketing challenges.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Hot Investor Mandate: VC Firm Invests in Seed & Venture Stage Medical Device & Diagnostics Companies in North America, with Strong USA Focus
29 OctSubscribe
Life Science Nation
RESI Conference Series
Investor Platform Demo
Company Platform Demo
Next Phase Newsletter 
Leave a Reply